When 99211 can be used with, or for, a Coumadin clinic visit

Why This Topic Matters

Coumadin clinic visits often involve overlapping monitoring, patient evaluation, and treatment management activities, which can create billing and documentation questions. Understanding the article helps practices align claim reporting, recordkeeping, and carrier-specific requirements for these encounters.

Article Sections

1. CMS guidance on Coumadin clinic encounters

   This section summarizes CMS commentary on the general nature of anticoagulant monitoring visits and how they are viewed in the clinic setting. It also introduces the documentation expectations associated with these encounters.

2. Definition of protime visit

   This section discusses how the article frames anticoagulant monitoring visits and the kinds of record elements CMS says should be reflected in the chart. It also addresses setting and personnel considerations tied to reporting.

3. Incident-to billing and carrier policy considerations

   This section covers CMS references to incident-to requirements and the role of local carrier policies in claims payment. It also notes that carrier guidance may affect how practices handle these services.

4. Examples of separately identifiable 99211 services

   This section presents a general discussion of circumstances in which an office visit may involve additional patient issues beyond routine anticoagulant monitoring. It highlights the article’s emphasis on overlapping clinical needs in these patients.